Dr. Peter Van, MD
NPI: 1134330400
Total Payments
$7,109
2024 Payments
$1,314
Companies
32
Transactions
242
Medicare Patients
3,417
Medicare Billing
$799,775
Payment Breakdown by Category
Food & Beverage$6,975 (98.1%)
Education$133.47 (1.9%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,975 | 234 | 98.1% |
| Education | $133.47 | 8 | 1.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $944.25 | 27 | $0 (2024) |
| Fresenius USA Marketing, Inc. | $667.36 | 32 | $0 (2024) |
| Melinta Therapeutics, LLC | $508.64 | 5 | $0 (2024) |
| Allergan, Inc. | $502.53 | 14 | $0 (2020) |
| Otsuka America Pharmaceutical, Inc. | $388.04 | 19 | $0 (2024) |
| Paratek Pharmaceuticals, Inc. | $374.99 | 3 | $0 (2021) |
| Amgen Inc. | $342.19 | 12 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $300.74 | 17 | $0 (2024) |
| The Medicines Company | $288.83 | 5 | $0 (2017) |
| CALLIDITAS THERAPEUTICS US INC. | $256.09 | 8 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,314 | 50 | Fresenius USA Marketing, Inc. ($393.69) |
| 2023 | $1,259 | 42 | Calliditas Therapeutics US Inc. ($158.25) |
| 2022 | $1,605 | 66 | Fresenius USA Marketing, Inc. ($273.67) |
| 2021 | $1,254 | 40 | AstraZeneca Pharmaceuticals LP ($468.78) |
| 2020 | $263.40 | 3 | Paratek Pharmaceuticals, Inc. ($124.99) |
| 2019 | $478.44 | 7 | AstraZeneca Pharmaceuticals LP ($140.30) |
| 2018 | $263.57 | 16 | Allergan Inc. ($163.16) |
| 2017 | $670.66 | 18 | The Medicines Company ($288.83) |
All Payment Transactions
242 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $16.59 | General |
| Category: IMMUNOLOGY | ||||||
| 12/06/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $18.27 | General |
| Category: Nephrology | ||||||
| 11/26/2024 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $20.16 | General |
| Category: Phosphate binder for ESRD | ||||||
| 11/25/2024 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $23.19 | General |
| Category: Phosphate binder for ESRD | ||||||
| 11/19/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $25.20 | General |
| Category: Cardio-renal | ||||||
| 11/01/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $20.27 | General |
| Category: Nephrology | ||||||
| 10/29/2024 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $22.01 | General |
| Category: Phosphate binder for ESRD | ||||||
| 10/28/2024 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $22.52 | General |
| Category: Phosphate binder for ESRD | ||||||
| 09/26/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $26.48 | General |
| Category: NEPHROLOGY | ||||||
| 08/06/2024 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $22.62 | General |
| Category: Phosphate binder for ESRD | ||||||
| 08/05/2024 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $22.27 | General |
| Category: Phosphate binder for ESRD | ||||||
| 07/19/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $29.78 | General |
| Category: NEPHROLOGY | ||||||
| 07/17/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $21.85 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/16/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $32.87 | General |
| Category: Inflammation/Rare Disease | ||||||
| 07/16/2024 | Amgen Inc. | Aranesp (Biological), Parsabiv, TAVNEOS | Food and Beverage | In-kind items and services | $22.84 | General |
| Category: Nephrology | ||||||
| 07/15/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $27.35 | General |
| Category: IMMUNOLOGY | ||||||
| 07/10/2024 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $15.46 | General |
| Category: Phosphate binder for ESRD | ||||||
| 07/09/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $19.81 | General |
| Category: IMMUNOLOGY | ||||||
| 07/09/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $18.96 | General |
| Category: Nephrology | ||||||
| 07/02/2024 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $21.37 | General |
| Category: Phosphate binder for ESRD | ||||||
| 06/18/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $27.26 | General |
| Category: NEPHROLOGY | ||||||
| 06/15/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $21.42 | General |
| Category: Diabetes | ||||||
| 05/29/2024 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $24.24 | General |
| Category: Phosphate binder for ESRD | ||||||
| 05/02/2024 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Education | In-kind items and services | $16.29 | General |
| Category: NEPHROLOGY | ||||||
| 04/30/2024 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $18.61 | General |
| Category: Phosphate binder for ESRD | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 862 | 2,169 | $319,143 | $233,247 |
| 2022 | 12 | 957 | 2,236 | $329,116 | $243,407 |
| 2021 | 14 | 904 | 2,135 | $362,716 | $212,157 |
| 2020 | 8 | 694 | 1,268 | $273,409 | $110,964 |
Total Patients
3,417
Total Services
7,808
Medicare Billing
$799,775
Procedure Codes
42
All Medicare Procedures & Services
42 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 292 | 941 | $117,665 | $87,639 | 74.5% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 51 | 227 | $82,150 | $61,727 | 75.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 219 | 563 | $47,770 | $34,749 | 72.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 114 | 222 | $29,035 | $19,010 | 65.5% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 26 | 53 | $16,165 | $12,043 | 74.5% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 107 | 109 | $15,478 | $11,036 | 71.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 37 | 38 | $7,980 | $5,160 | 64.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 16 | 16 | $2,900 | $1,883 | 64.9% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2022 | 61 | 279 | $100,440 | $77,639 | 77.3% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 280 | 820 | $90,695 | $65,330 | 72.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 192 | 562 | $43,090 | $31,314 | 72.7% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2022 | 46 | 87 | $26,935 | $20,273 | 75.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 128 | 209 | $27,205 | $19,252 | 70.8% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 74 | 78 | $11,076 | $8,210 | 74.1% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 35 | 35 | $7,350 | $5,429 | 73.9% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2022 | 53 | 73 | $5,840 | $4,166 | 71.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 33 | 33 | $5,775 | $4,072 | 70.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 22 | 22 | $5,060 | $3,603 | 71.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 20 | 24 | $4,320 | $3,197 | 74.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 13 | 14 | $1,330 | $922.63 | 69.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 273 | 864 | $136,887 | $69,287 | 50.6% |
| 90960 | Dialysis services (4 or more physician visits per month), patient 20 years of age and older | Office | 2021 | 69 | 174 | $63,930 | $48,962 | 76.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 115 | 592 | $55,956 | $33,732 | 60.3% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 105 | 107 | $35,134 | $16,207 | 46.1% |
| 90961 | Dialysis services (2-3 physician visits per month), patient 20 years of age and older | Office | 2021 | 28 | 47 | $14,735 | $10,995 | 74.6% |
About Dr. Peter Van, MD
Dr. Peter Van, MD is a Student in an Organized Health Care Education/Training Program healthcare provider based in Covington, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/25/2007. The National Provider Identifier (NPI) number assigned to this provider is 1134330400.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Peter Van, MD has received a total of $7,109 in payments from pharmaceutical and medical device companies, with $1,314 received in 2024. These payments were reported across 242 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($6,975).
As a Medicare-enrolled provider, Van has provided services to 3,417 Medicare beneficiaries, totaling 7,808 services with total Medicare billing of $799,775. Data is available for 4 years (2020–2023), covering 42 distinct procedure/service records.
Ad
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Other Specialties Nephrology
- Location Covington, LA
- Active Since 05/25/2007
- Last Updated 12/23/2014
- Taxonomy Code 390200000X
- Entity Type Individual
- NPI Number 1134330400
Products in Payments
- Velphoro (Drug) $667.36
- LOKELMA (Drug) $648.14
- JYNARQUE (Drug) $375.83
- NUZYRA (Drug) $374.99
- DALVANCE (Drug) $371.25
- Kerendia (Drug) $300.74
- KRYSTEXXA (Biological) $289.02
- FARXIGA (Drug) $274.61
- TARPEYO (Drug) $256.09
- Kimyrsa (Drug) $243.96
- AVYCAZ (Drug) $241.80
- ELIQUIS (Drug) $183.68
- Auryxia (Drug) $180.11
- ACTHAR (Biological) $175.83
- ORBACTIV (Drug) $156.97
- TEFLARO (Drug) $139.48
- ZERBAXA (Drug) $136.38
- TAVNEOS (Drug) $132.50
- Parsabiv (Drug) $131.44
- Veltassa (Drug) $129.52
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in Covington
Smitty Smith
Student in an Organized Health Care Education/Training Program — Payments: $17,749
Student in an Organized Health Care Education/Training Program $17,749
Brandon Brousse, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $11,333
Student in an Organized Health Care Education/Training Program $11,333
Dr. Emily Grieshaber, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $10,951
Student in an Organized Health Care Education/Training Program $10,951
Stratton Grisoli, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $6,225
Student in an Organized Health Care Education/Training Program $6,225
Michelle Haggar, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $5,426
Student in an Organized Health Care Education/Training Program $5,426
Dr. Samantha Karlin, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $4,702
Student in an Organized Health Care Education/Training Program $4,702